Literature DB >> 33397959

Global computational alignment of tumor and cell line transcriptional profiles.

Allison Warren1, Yejia Chen1, Andrew Jones1, Tsukasa Shibue1, William C Hahn1,2,3, Jesse S Boehm1, Francisca Vazquez1, Aviad Tsherniak1, James M McFarland4.   

Abstract

Cell lines are key tools for preclinical cancer research, but it remains unclear how well they represent patient tumor samples. Direct comparisons of tumor and cell line transcriptional profiles are complicated by several factors, including the variable presence of normal cells in tumor samples. We thus develop an unsupervised alignment method (Celligner) and apply it to integrate several large-scale cell line and tumor RNA-Seq datasets. Although our method aligns the majority of cell lines with tumor samples of the same cancer type, it also reveals large differences in tumor similarity across cell lines. Using this approach, we identify several hundred cell lines from diverse lineages that present a more mesenchymal and undifferentiated transcriptional state and that exhibit distinct chemical and genetic dependencies. Celligner could be used to guide the selection of cell lines that more closely resemble patient tumors and improve the clinical translation of insights gained from cell lines.

Entities:  

Year:  2021        PMID: 33397959     DOI: 10.1038/s41467-020-20294-x

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  66 in total

Review 1.  From cell lines to living biosensors: new opportunities to prioritize cancer dependencies using ex vivo tumor cultures.

Authors:  Yuen-Yi Tseng; Jesse S Boehm
Journal:  Curr Opin Genet Dev       Date:  2019-03-28       Impact factor: 5.578

2.  Defining a Cancer Dependency Map.

Authors:  Aviad Tsherniak; Francisca Vazquez; Phil G Montgomery; Barbara A Weir; Gregory Kryukov; Glenn S Cowley; Stanley Gill; William F Harrington; Sasha Pantel; John M Krill-Burger; Robin M Meyers; Levi Ali; Amy Goodale; Yenarae Lee; Guozhi Jiang; Jessica Hsiao; William F J Gerath; Sara Howell; Erin Merkel; Mahmoud Ghandi; Levi A Garraway; David E Root; Todd R Golub; Jesse S Boehm; William C Hahn
Journal:  Cell       Date:  2017-07-27       Impact factor: 41.582

3.  Intramucosal activation of pepsinogens in the pathogenesis of acute gastric erosions and their prevention by the potent semisynthetic amphipathic inhibitor pepstatinyl-glycyl-lysyl-lysine.

Authors:  T F Ford; D A Grant; B M Austen; J Hermon-Taylor
Journal:  Clin Chim Acta       Date:  1985-01-15       Impact factor: 3.786

Review 4.  Emerging Opportunities for Target Discovery in Rare Cancers.

Authors:  Tanaz Sharifnia; Andrew L Hong; Corrie A Painter; Jesse S Boehm
Journal:  Cell Chem Biol       Date:  2017-09-21       Impact factor: 8.116

5.  Next-generation characterization of the Cancer Cell Line Encyclopedia.

Authors:  Mahmoud Ghandi; Franklin W Huang; Judit Jané-Valbuena; Gregory V Kryukov; Christopher C Lo; E Robert McDonald; Jordi Barretina; Ellen T Gelfand; Craig M Bielski; Haoxin Li; Kevin Hu; Alexander Y Andreev-Drakhlin; Jaegil Kim; Julian M Hess; Brian J Haas; François Aguet; Barbara A Weir; Michael V Rothberg; Brenton R Paolella; Michael S Lawrence; Rehan Akbani; Yiling Lu; Hong L Tiv; Prafulla C Gokhale; Antoine de Weck; Ali Amin Mansour; Coyin Oh; Juliann Shih; Kevin Hadi; Yanay Rosen; Jonathan Bistline; Kavitha Venkatesan; Anupama Reddy; Dmitriy Sonkin; Manway Liu; Joseph Lehar; Joshua M Korn; Dale A Porter; Michael D Jones; Javad Golji; Giordano Caponigro; Jordan E Taylor; Caitlin M Dunning; Amanda L Creech; Allison C Warren; James M McFarland; Mahdi Zamanighomi; Audrey Kauffmann; Nicolas Stransky; Marcin Imielinski; Yosef E Maruvka; Andrew D Cherniack; Aviad Tsherniak; Francisca Vazquez; Jacob D Jaffe; Andrew A Lane; David M Weinstock; Cory M Johannessen; Michael P Morrissey; Frank Stegmeier; Robert Schlegel; William C Hahn; Gad Getz; Gordon B Mills; Jesse S Boehm; Todd R Golub; Levi A Garraway; William R Sellers
Journal:  Nature       Date:  2019-05-08       Impact factor: 49.962

6.  Evaluating cell lines as tumour models by comparison of genomic profiles.

Authors:  Silvia Domcke; Rileen Sinha; Douglas A Levine; Chris Sander; Nikolaus Schultz
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

7.  Investigating the utility of human melanoma cell lines as tumour models.

Authors:  Krista Marie Vincent; Lynne-Marie Postovit
Journal:  Oncotarget       Date:  2017-02-07

8.  Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells.

Authors:  Robin M Meyers; Jordan G Bryan; James M McFarland; Barbara A Weir; Ann E Sizemore; Han Xu; Neekesh V Dharia; Phillip G Montgomery; Glenn S Cowley; Sasha Pantel; Amy Goodale; Yenarae Lee; Levi D Ali; Guozhi Jiang; Rakela Lubonja; William F Harrington; Matthew Strickland; Ting Wu; Derek C Hawes; Victor A Zhivich; Meghan R Wyatt; Zohra Kalani; Jaime J Chang; Michael Okamoto; Kimberly Stegmaier; Todd R Golub; Jesse S Boehm; Francisca Vazquez; David E Root; William C Hahn; Aviad Tsherniak
Journal:  Nat Genet       Date:  2017-10-30       Impact factor: 38.330

9.  Improved estimation of cancer dependencies from large-scale RNAi screens using model-based normalization and data integration.

Authors:  James M McFarland; Zandra V Ho; Guillaume Kugener; Joshua M Dempster; Phillip G Montgomery; Jordan G Bryan; John M Krill-Burger; Thomas M Green; Francisca Vazquez; Jesse S Boehm; Todd R Golub; William C Hahn; David E Root; Aviad Tsherniak
Journal:  Nat Commun       Date:  2018-11-02       Impact factor: 14.919

10.  Genetic and transcriptional evolution alters cancer cell line drug response.

Authors:  Uri Ben-David; Benjamin Siranosian; Gavin Ha; Helen Tang; Yaara Oren; Kunihiko Hinohara; Craig A Strathdee; Joshua Dempster; Nicholas J Lyons; Robert Burns; Anwesha Nag; Guillaume Kugener; Beth Cimini; Peter Tsvetkov; Yosef E Maruvka; Ryan O'Rourke; Anthony Garrity; Andrew A Tubelli; Pratiti Bandopadhayay; Aviad Tsherniak; Francisca Vazquez; Bang Wong; Chet Birger; Mahmoud Ghandi; Aaron R Thorner; Joshua A Bittker; Matthew Meyerson; Gad Getz; Rameen Beroukhim; Todd R Golub
Journal:  Nature       Date:  2018-08-08       Impact factor: 49.962

View more
  19 in total

1.  Transition to a mesenchymal state in neuroblastoma confers resistance to anti-GD2 antibody via reduced expression of ST8SIA1.

Authors:  Nathaniel W Mabe; Min Huang; Guillermo N Dalton; Gabriela Alexe; Daniel A Schaefer; Anna C Geraghty; Amanda L Robichaud; Amy S Conway; Delan Khalid; Marius M Mader; Julia A Belk; Kenneth N Ross; Michal Sheffer; Miles H Linde; Nghi Ly; Winnie Yao; Maria Caterina Rotiroti; Benjamin A H Smith; Marius Wernig; Carolyn R Bertozzi; Michelle Monje; Constantine S Mitsiades; Ravindra Majeti; Ansuman T Satpathy; Kimberly Stegmaier; Robbie G Majzner
Journal:  Nat Cancer       Date:  2022-07-11

2.  CNpare: matching DNA copy number profiles.

Authors:  Blas Chaves-Urbano; Barbara Hernando; Maria J Garcia; Geoff Macintyre
Journal:  Bioinformatics       Date:  2022-05-31       Impact factor: 6.931

Review 3.  Computational estimation of quality and clinical relevance of cancer cell lines.

Authors:  Lucia Trastulla; Javad Noorbakhsh; Francisca Vazquez; James McFarland; Francesco Iorio
Journal:  Mol Syst Biol       Date:  2022-07       Impact factor: 13.068

4.  Integrating molecular profiles into clinical frameworks through the Molecular Oncology Almanac to prospectively guide precision oncology.

Authors:  Brendan Reardon; Nathanael D Moore; Nicholas S Moore; Eric Kofman; Saud H AlDubayan; Alexander T M Cheung; Jake Conway; Haitham Elmarakeby; Alma Imamovic; Sophia C Kamran; Tanya Keenan; Daniel Keliher; David J Konieczkowski; David Liu; Kent W Mouw; Jihye Park; Natalie I Vokes; Felix Dietlein; Eliezer M Van Allen
Journal:  Nat Cancer       Date:  2021-09-30

5.  Bridging the gap between cancer cell line models and tumours using gene expression data.

Authors:  Javad Noorbakhsh; Francisca Vazquez; James M McFarland
Journal:  Br J Cancer       Date:  2021-03-29       Impact factor: 7.640

Review 6.  Artificial Intelligence in Bulk and Single-Cell RNA-Sequencing Data to Foster Precision Oncology.

Authors:  Marco Del Giudice; Serena Peirone; Sarah Perrone; Francesca Priante; Fabiola Varese; Elisa Tirtei; Franca Fagioli; Matteo Cereda
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

7.  A first-generation pediatric cancer dependency map.

Authors:  Neekesh V Dharia; Guillaume Kugener; Lillian M Guenther; Clare F Malone; Adam D Durbin; Andrew L Hong; Thomas P Howard; Pratiti Bandopadhayay; Caroline S Wechsler; Iris Fung; Allison C Warren; Joshua M Dempster; John M Krill-Burger; Brenton R Paolella; Phoebe Moh; Nishant Jha; Andrew Tang; Philip Montgomery; Jesse S Boehm; William C Hahn; Charles W M Roberts; James M McFarland; Aviad Tsherniak; Todd R Golub; Francisca Vazquez; Kimberly Stegmaier
Journal:  Nat Genet       Date:  2021-03-22       Impact factor: 38.330

8.  Functional Impact of Genomic Complexity on the Transcriptome of Multiple Myeloma.

Authors:  Bachisio Ziccheddu; Matteo C Da Vià; Francesco Maura; Niccolò Bolli; Marta Lionetti; Akihiro Maeda; Silvia Morlupi; Matteo Dugo; Katia Todoerti; Stefania Oliva; Mattia D'Agostino; Paolo Corradini; Ola Landgren; Francesco Iorio; Loredana Pettine; Alessandra Pompa; Martina Manzoni; Luca Baldini; Antonino Neri
Journal:  Clin Cancer Res       Date:  2021-09-15       Impact factor: 12.531

9.  Bi-order multimodal integration of single-cell data.

Authors:  Jinzhuang Dou; Shaoheng Liang; Vakul Mohanty; Qi Miao; Yuefan Huang; Qingnan Liang; Xuesen Cheng; Sangbae Kim; Jongsu Choi; Yumei Li; Li Li; May Daher; Rafet Basar; Katayoun Rezvani; Rui Chen; Ken Chen
Journal:  Genome Biol       Date:  2022-05-09       Impact factor: 17.906

10.  Predicting patient response with models trained on cell lines and patient-derived xenografts by nonlinear transfer learning.

Authors:  Soufiane M C Mourragui; Marco Loog; Daniel J Vis; Kat Moore; Anna G Manjon; Mark A van de Wiel; Marcel J T Reinders; Lodewyk F A Wessels
Journal:  Proc Natl Acad Sci U S A       Date:  2021-12-07       Impact factor: 12.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.